Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy

Table 4 Univariant and multivariant analysis of potential factors associated with postoperative complications

	Overall morbidity			Major morbidity
	(grade I–V)			(grade III–V)
	Univariant	Multivariant		Univariant	Multivariant
Variables	P value	P value	OR(95 % CI)	P value	P value	OR(95 % CI)
Anemia (Y/N)	0.023	0.015	2.626(1.204–5.728)	0.473	-	-
Time interval from disease onset to surgery (<6 m/>6 m)	0.000	0.062	0.527(0.269–1.364)	0.181	-	-
Chemotherapy (Y/N)	0.023	0.307	0.7(0.353–1.388)	1.000	-	-
Operation time	0.092	0.210	1.588(0.770–3.277)	0.816	-	-
(<150/>150) min
Adhesion states in surgical site (IV-V/I-III)	0.046	0.089	2.180(0.887–5.360)	0.066	0.017	3.535(1.250–10.001)
ASA grade (III–V/I-II)	1.000	-	-	0.014	0.022	3.400(1.197–9.653)
RTOG/ETORC Grade IV late morbidity (Y/N)	0.129	-	-	0.001	0.018	0.171(0.040–0.735)
Stomy surgery (Y/N)	0.617	-	-	0.039	0.575	1.723(0.257–11.546)
Staged surgery (I/II)	0.492	-	-	0.099	0.735	0.731(0.120–4.474)
Age (<50/>50) y	0.624	-	-	1.000	-	-
Tumor stage (I-IIa/IIb-V)	0.496	-	-	0.702	-	-
Pathological type (squamous carcinoma/adenocarcinoma)	0.710	-	-	1.000	-	--
Radiation dosage (Gy)	0.373	-	-	0.379	-	-
Acute radiation enteritis (Y/N)	0.475	-	-	0.807	-	-
Previous abdominal surgery (Y/N)	0.345	-	-	0.789	-	-
Latency period (m)	0.194	-	-	0.369	-	-
Hypertention (Y/N)	0.569	-	-	0.108	-	-
Diabetes mellitus (Y/N)	0.616	-	-	0.453	-	-
BMI < 18.5 and weight loss >10 %	0.217	-	-	1.000	-	-
Preoperative TPN (Y/N)	0.407	-	-	0.493	-	-
Short bowel syndrome (Y/N)	0.330	-	-	1.000	-	-

RTOG/ETORC the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), ASA American Society of Anesthesiologists, BMI Body mass Index

ISSN: 1748-717X